Marta Wawro

Dr. Marta Wawro

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
WCWojciech Ciszewski
Wojciech Ciszewski
MWMarta Wawro
Marta Wawro
ISIzabela Sacewicz-hofman
Izabela Sacewicz-hofman
Katarzyna SobierajskaKatarzyna Sobierajska
Katarzyna Sobierajska
Chronic inflammation promotes endothelial plasticity, leading to the development of several diseases, including fibrosis and cancer in numerous organs. The basis of those processes is a phenomenon called the endothelial–mesenchymal transition (EndMT), which results in the delamination of tightly connected endothelial cells that acquire a mesenchymal phenotype. EndMT-derived cells, known as the myofibroblasts or cancer-associated fibroblasts (CAFs), are characterized by the loss of cell–cell junctions, loss of endothelial markers, and gain in mesenchymal ones. As a result, the endothelium ceases its primary ability to maintain patent and functional capillaries and induce new blood vessels. At the same time, it acquires the migration and invasion potential typical of mesenchymal cells. The observed modulation of cell shape, increasedcell movement, and invasion abilities are connected with cytoskeleton reorganization. This paper focuses on the review of current knowledge about the molecular pathways involved in the modulation of each cytoskeleton element (microfilaments, microtubule, and intermediate filaments) during EndMT and their role as the potential targets for cancer and fibrosis treatment.

1 September 2016 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
Katarzyna SobierajskaKatarzyna Sobierajska
Katarzyna Sobierajska
Katarzyna Wieczorek-SzukałaKatarzyna Wieczorek-Szukała
Katarzyna Wieczorek-Szukała
WCWojciech Ciszewski
Wojciech Ciszewski
ISIzabela Sacewicz-hofman
Izabela Sacewicz-hofman
MWMarta Wawro
Marta Wawro
Jolanta Maria NiewiarowskaJolanta Maria Niewiarowska
Jolanta Maria Niewiarowska

1 December 2017 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
WCWojciech Ciszewski
Wojciech Ciszewski
Katarzyna SobierajskaKatarzyna Sobierajska
Katarzyna Sobierajska
MWMarta Wawro
Marta Wawro
WKWanda Klopocka
Wanda Klopocka
NCNatasza Chefczyńska
Natasza Chefczyńska
Jolanta Maria NiewiarowskaJolanta Maria Niewiarowska
Jolanta Maria Niewiarowska

1 October 2017 in Cellular Signalling
Verified
Journal Article
Closed access
MWMarta Wawro
Marta Wawro
Katarzyna SobierajskaKatarzyna Sobierajska
Katarzyna Sobierajska
WCWojciech Ciszewski
Wojciech Ciszewski
WWWaldemar Wagner
Waldemar Wagner
MFMarta Frontczak
Marta Frontczak
Jolanta Maria NiewiarowskaJolanta Maria Niewiarowska
Jolanta Maria Niewiarowska

1 August 2019 in Cells
Verified
Journal Article
Open access
PDF file
Katarzyna SobierajskaKatarzyna Sobierajska
Katarzyna Sobierajska
WCWojciech Ciszewski
Wojciech Ciszewski
MWMarta Wawro
Marta Wawro
Katarzyna Wieczorek-SzukałaKatarzyna Wieczorek-Szukała
Katarzyna Wieczorek-Szukała
JBJoanna Boncela
Joanna Boncela
MKMaria Anna Kowalska
Maria Anna Kowalska
Tumor metastasis, the major problem for clinical oncology in colon cancer treatment, is linked with an epithelial-mesenchymal transition (EMT). The observed cellular transformation in this process is manifested by cell elongation, enhanced cell migration and invasion ability, coordinated by cytoskeleton reorganization. In the present study, we examined the role of tubulin-β4 (TUBB4B) downregulation that occurs during EMT in colon cancer cells, in the modulation of the function of microtubules. Based on biochemical and behavioral analysis (transmigration) we posit that the decrease of the TUBB4B level is critical for microtubule-vimentin interaction and contributes to the maintenance of polarity in migrating cells. The microscopic studies revealed that TUBB4B decrease is accompanied by cell elongation and increased number of matured focal adhesion sites, which is a characteristic of the cell metastatic stage. We also demonstrated faster polymerization of microtubules in cells with a lower level of TUBB4B. Simultaneous TUBB3 upregulation, reported during EMT, acts additively in this process. Our studies suggest that the protein level of TUBB4B could be used as a marker for detection of the preinvasive stages of the colon cancer cells. We also concluded that chemotherapy enriched to increase TUBB4B level and/or to stabilize microtubule polymerization might more effectively prevent metastasis in colon cancer development.

Verified
Journal Article
Open access
PDF file
MWMarta Wawro
Marta Wawro
KCKatarzyna Chojnacka
Katarzyna Chojnacka
Katarzyna Wieczorek-SzukałaKatarzyna Wieczorek-Szukała
Katarzyna Wieczorek-Szukała
Katarzyna SobierajskaKatarzyna Sobierajska
Katarzyna Sobierajska
Jolanta Maria NiewiarowskaJolanta Maria Niewiarowska
Jolanta Maria Niewiarowska
Colon cancer, the second leading cause of cancer-related deaths in the world, is usually diagnosed in invasive stages. The interactions between cancer cells and cells located in their niche remain the crucial mechanism inducing tumor metastasis. The most important among those cells are cancer-associated fibroblasts (CAFs), the heterogeneous group of myofibroblasts transdifferentiated from numerous cells of different origin, including endothelium. The endothelial-to-mesenchymal transition (EndMT) is associated with modulation of cellular morphology, polarization and migration ability as a result of microtubule cytoskeleton reorganization. Here we reveal, for the first time, that invasive colon cancer cells regulate EndMT of endothelium via tubulin-β3 upregulation and its phosphorylation. Thus, we concluded that therapies based on inhibition of tubulin-β3 expression or phosphorylation, or blocking tubulin-β3’s recruitment to the microtubules, together with anti-inflammatory chemotherapeutics, are promising means to treat advanced stages of colon cancer.